Top compounds associated with response to LRRC46


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K33199242 CTRPv2 pan-cancer AAC -0.016 0.7
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.015 0.7
mRNA UNC1215 GDSC1000 pan-cancer AAC 0.015 0.7
mRNA SID 26681509 CTRPv2 pan-cancer AAC 0.016 0.7
mRNA myricetin CTRPv2 pan-cancer AAC 0.016 0.7
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.015 0.7
mRNA BRD-K63431240 CTRPv2 pan-cancer AAC 0.015 0.7
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.015 0.7
mRNA LY-2183240 CTRPv2 pan-cancer AAC -0.013 0.7
mRNA BRD9647 CTRPv2 pan-cancer AAC -0.015 0.7
Download CSV